INTERNATIONAL PATENT: SAMJIN PHARMACEUTICAL CO., LTD., 삼진제약주식회사 FILES APPLICATION FOR "NR2F6 INHIBITOR AND USES THEREOF"

GENEVA, Dec. 9 -- SAMJIN PHARMACEUTICAL CO., LTD. (121 Wausan-roMapo-guSeoul 04054), 삼진제약주식회사 (서울특별시마포구와우산로 121) filed a patent application (PCT/IB2025/055558) for "NR2F6 INHIBITOR AND USES THEREOF" on May 29, 2025. With publication no. WO/2025/248483, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SONG, Eunsun (329 Hwagok-roGangseo-guSeoul 07649), 송은선 (서&...